Idiopathic disease
MONDO:0700007A disease or disorder for which the cause is of uncertain or unknown.
Also known as: idiopathic disorder
1282 clinical trials for this condition and its sub-types, 1 tagged with Idiopathic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Idiopathic disease
-
Fibromyalgia 279 trials
-
Idiopathic interstitial pneumonia 10 trials · 219 incl. sub-types
10 sub-types
- Idiopathic pulmonary fibrosis 202 trials
- Non-specific interstitial pneumonia 14 trials
- Lymphoid interstitial pneumonia 7 trials
- Combined pulmonary fibrosis-emphysema syndrome 3 trials
- Cryptogenic organizing pneumonia 3 trials
- Idiopathic pleuroparenchymal fibroelastosis 1 trial
- Acute interstitial pneumonia 0 trials
- Desquamative interstitial pneumonia 0 trials
- Follicular bronchiolits 0 trials
- Respiratory bronchiolitis-interstitial lung disease syndrome 0 trials
-
Idiopathic scoliosis 66 trials · 181 incl. sub-types
2 sub-types
- Adolescent idiopathic scoliosis 137 trials
- Juvenile idiopathic scoliosis 9 trials
-
Acquired idiopathic inflammatory myopathy 67 trials · 159 incl. sub-types
9 sub-types
- Polymyositis 36 trials · 100 incl. sub-types Sub-types →
- Juvenile idiopathic inflammatory myopathy 2 trials · 42 incl. sub-types Sub-types →
- Antisynthetase syndrome 21 trials
- Immune-mediated necrotizing myopathy 17 trials
- Overlap myositis 2 trials
- Eosinophilic fasciitis 1 trial
- Focal myositis 0 trials
- Idiopathic eosinophilic myositis 0 trials
- Inflammatory myopathy with abundant macrophages 0 trials
-
Juvenile idiopathic arthritis 107 trials · 115 incl. sub-types
6 sub-types
- Systemic-onset juvenile idiopathic arthritis 25 trials
- Polyarticular juvenile idiopathic arthritis 14 trials · 16 incl. sub-types Sub-types →
- Psoriasis-related juvenile idiopathic arthritis 15 trials
- Enthesitis-related juvenile idiopathic arthritis 7 trials
- Oligoarticular juvenile idiopathic arthritis 5 trials Sub-types →
- Unspecified juvenile idiopathic arthritis 0 trials
-
Idiopathic urticaria 0 trials · 66 incl. sub-types
2 sub-types
- Chronic idiopathic urticaria 65 trials
- Acute idiopathic urticaria 1 trial
-
Idiopathic membranous glomerulonephritis 50 trials
-
Idiopathic hypersomnia 28 trials
2 sub-types
-
Idiopathic nephrotic syndrome 13 trials · 24 incl. sub-types
5 sub-types
- Idiopathic multidrug-resistant nephrotic syndrome 6 trials
- Idiopathic steroid-sensitive nephrotic syndrome 4 trials Sub-types →
- Sporadic idiopathic steroid-resistant nephrotic syndrome 0 trials · 2 incl. sub-types Sub-types →
- Familial idiopathic steroid-resistant nephrotic syndrome 0 trials Sub-types →
- Idiopathic steroid-resistant nephrotic syndrome with sensitivity to second-line immunosuppressive therapy 0 trials
-
Sudden unexpected death in pediatrics 1 trial · 17 incl. sub-types
2 sub-types
- Sudden unexpected infant death 15 trials
- Sudden unexplained death in childhood 1 trial
-
Idiopathic bilateral vestibulopathy 14 trials
-
Idiopathic achalasia 12 trials
-
Pediatric acute-onset neuropsychiatric syndrome 8 trials · 10 incl. sub-types
1 sub-type
- PANDAS 6 trials
-
Idiopathic aplastic anemia 9 trials
-
Persistent idiopathic facial pain 9 trials
-
Idiopathic gastroparesis 8 trials
-
Idiopathic recurrent pericarditis 8 trials
-
Idiopathic CD4 lymphocytopenia 7 trials
-
Idiopathic camptocormia 7 trials
-
Idiopathic torsion dystonia 6 trials
2 sub-types
- Acquired idiopathic torsion dystonia 0 trials
- Familial idiopathic torsion dystonia 0 trials
-
Chronic idiopathic neuropathy 5 trials
-
Idiopathic bronchiectasis 3 trials
-
Idiopathic hypercalciuria 3 trials
-
Idiopathic cardiomyopathy 2 trials · 3 incl. sub-types
2 sub-types
-
Idiopathic anaphylaxis 1 trial
-
Idiopathic avascular necrosis 1 trial
-
Idiopathic posterior uveitis 1 trial
-
Macular telangiectasia type 1 1 trial
-
Benign idiopathic neonatal seizures 0 trials
-
Idiopathic acute transverse myelitis 0 trials
-
Idiopathic anterior uveitis 0 trials
-
Idiopathic congenital hypothyroidism 0 trials
-
Idiopathic corneal edema 0 trials
-
Idiopathic dropped head syndrome 0 trials
-
Idiopathic ductopenia 0 trials
-
Idiopathic eosinophilic pneumonia 0 trials
2 sub-types
-
Idiopathic granulomatous myositis 0 trials
-
Idiopathic juvenile osteoporosis 0 trials
-
Idiopathic localized lipodystrophy 0 trials
-
Idiopathic neonatal atrial flutter 0 trials
-
Idiopathic panuveitis 0 trials
1 sub-type
- Idiopathic uveal effusion syndrome 0 trials
-
Idiopathic peliosis hepatis 0 trials
-
Idiopathic recurrent stupor 0 trials
-
Idiopathic severe pneumococcemia 0 trials
-
Idiopathic syringomyelia 0 trials
-
Macular telangiectasia type 3 0 trials
-
Polyhydramnios, chronic idiopathic 0 trials
-
Priapism, familial idiopathic 0 trials
-
Recurrent idiopathic neuroretinitis 0 trials
Most studied deeper sub-types
-
New hope for lung scarring? trial of GSK3915393 cut short
Disease control Stopped earlyThis study tested a new medicine, GSK3915393, in 158 people with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and breathing difficulty. The goal was to see if the drug could slow lung function decline compared to a placebo. The trial was termin…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an oral drug calm inflamed muscles in myositis?
Disease control Stopped earlyResearchers are testing an experimental oral drug called enpatoran in adults with dermatomyositis and polymyositis, two rare muscle-weakening diseases. Participants receive enpatoran or a placebo twice daily for up to 24 weeks while continuing their standard care. The trial measu…
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental antibody takes aim at eye inflammation
Disease control Stopped earlyThis study tests an experimental drug called REGN7041 in 72 people with active noninfectious uveitis, a condition causing inflammation inside the eye. The drug is an antibody designed to calm the immune system. Since this is the first time it's tested in humans, the main goal is …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a Blood-Cleansing combo tame deadly lung Flare-Ups?
Disease control Stopped earlyThis trial tests whether a combination of plasma exchange, rituximab, and intravenous immunoglobulins can improve survival in people hospitalized in intensive care with a severe acute exacerbation of idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease, and thes…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of chronic hives
Disease control Stopped earlyThis study is testing the long-term safety and effectiveness of a drug called briquilimab for people with chronic hives. It includes 67 participants who have already completed a previous trial with the same drug. The goal is to see if briquilimab remains safe and helps control hi…
Phase 2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new pill slow lung scarring in IPF?
Disease control Stopped earlyThis clinical trial is testing an investigational drug called bexotegrast (PLN-74809) in people with idiopathic pulmonary fibrosis (IPF), a disease that causes progressive lung scarring and breathing difficulties. The study will compare different doses of bexotegrast against a pl…
Phase 2 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New arthritis drug trial for kids: could filgotinib help?
Disease control Stopped earlyThis study is testing the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA), a condition causing joint pain and swelling. The goal is to see how the drug moves through the body and if it is safe. Ten children with moderate to severe JIA that is not…
Phase 1 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Heart drug study halted early: limited data on right heart changes
Disease control Stopped earlyThis study looked at whether the drug riociguat could improve right heart size and function in people with two types of pulmonary hypertension (PAH and CTEPH). It planned to enroll 30 adults, but was terminated early, so results are limited. The goal was to use echocardiograms to…
Phase 4 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can an extra shot boost COVID protection in autoimmune patients?
Disease control Stopped earlyThis study tests whether an additional dose of a COVID-19 vaccine can improve immune protection in adults and children with autoimmune diseases like rheumatoid arthritis, lupus, multiple sclerosis, and others who are taking immunosuppressive medications. Participants who had a we…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Anti-Inflammatory drug studied for PANDAS-Related OCD in kids
Disease control Stopped earlyThis study tested the anti-inflammatory drug naproxen sodium for treating obsessive-compulsive symptoms in children aged 6-15 with PANDAS, a condition linked to strep infections. The trial was double-blind and placebo-controlled, but it was terminated early after enrolling only 2…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New combo therapy for rare blood disorder shows promise
Disease control Stopped earlyThis study looked at whether adding a drug called G-CSF to the usual treatment (ATG and Cyclosporin A) helps people with newly diagnosed severe aplastic anemia. Severe aplastic anemia is a rare condition where the bone marrow stops making enough blood cells. The trial included 20…
Phase 3 • Sponsor: European Society for Blood and Marrow Transplantation • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New device aims to straighten spines in kids without surgery
Disease control Stopped earlyThis study tested a device called the Braive Growth Modulation System in 10 children with scoliosis (curved spine). The goal was to see if it could safely correct the curve as the child grows. The study was stopped early, so results are limited.
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Brace yourself: new study tests if back braces really work for scoliosis
Disease control Stopped earlyThis study looked at whether wearing a back brace can stop spine curves from getting worse in teens with scoliosis. About 383 teens with mild to moderate curves were either assigned to wear a brace for at least 18 hours a day or just be observed. The goal was to see if bracing le…
Sponsor: Stuart L. Weinstein, MD • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Kidney disease drug trial halted early after only 6 patients
Disease control Stopped earlyThis early-stage study tested a new drug called VB119 in 6 adults with primary membranous nephropathy, a kidney disease. The main goal was to check safety and how the body handles the drug, not to cure the disease. The study was terminated early, so results are limited.
Phase 1/2 • Sponsor: Tenet Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental drug vixarelimab tested for two scarring lung diseases
Disease control Stopped earlyThis study tested the drug vixarelimab against a placebo in people with idiopathic pulmonary fibrosis (IPF) or systemic sclerosis-associated interstitial lung disease (SSc-ILD). The goal was to see if it could preserve lung function over 52 weeks. The trial was terminated early, …
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill for chronic hives and skin disease tested – but study halted early
Disease control Stopped earlyThis study tested an oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). The trial was open-label and lasted 28 days of treatment plus follow-up. It aimed to check safety…
Phase 2 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Common diabetes and acne drugs studied for head and neck cancer treatment
Disease control Stopped earlyThis study tested whether metformin (a diabetes drug) and doxycycline (an antibiotic) could help treat head and neck cancer when taken before surgery. The trial aimed to see if these drugs could change certain proteins in the tumor's supportive tissue. Only 7 people took part bef…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Eye drug trial for rare macular disease stops early – only 16 patients enrolled
Disease control Stopped earlyThis phase 3 trial tested aflibercept (Eylea) eye injections against placebo in 16 people with macular telangiectasia type 1, a rare condition that causes vision loss. The study aimed to see if aflibercept could reduce swelling in the macula. However, the trial was terminated ear…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Early-Stage lung blood pressure drug trial halted
Disease control Stopped earlyThis study tested the drug riociguat in people with early pulmonary vascular disease, a condition where blood vessels in the lungs narrow, making the heart work harder. The trial included 35 adults with connective tissue disease or an inherited form. Participants received either …
Phase 2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Lung fibrosis drug study halted early
Disease control Stopped earlyThis study tested new single treatments for idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and makes breathing hard. It included 46 adults aged 40 and older with mild to moderate IPF. The main goal was to see if the treatments improved lung function, mea…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Hizentra shows promise for rare muscle and skin disease
Disease control Stopped earlyThis study tested a medicine called Hizentra (IgPro20) in 134 adults with dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if weekly shots under the skin could improve symptoms better than a placebo. The study was stopped early, but res…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Kidney disease drug combo shows promise in small trial
Disease control Stopped earlyThis study looked at whether adding cyclosporine to rituximab is more effective than rituximab alone for treating idiopathic membranous nephropathy, a kidney disease that causes protein leakage. Only 12 adults with severe proteinuria took part before the study ended early. The go…
Phase 3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Promising IPF drug trial halted midway
Disease control Stopped earlyThis study tested an experimental drug called HZN-825 in people with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and makes breathing hard. The trial aimed to see if the drug could slow the decline in lung function over a year. About 153 adults with IP…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Lung disease drug tested in rare muscle condition – trial cut short
Disease control Stopped earlyThis study tested the drug nintedanib (Ofev) in 11 people with myositis-related interstitial lung disease, a condition where lung scarring occurs alongside muscle inflammation. The goal was to see if the drug is safe and tolerable when added to standard immune-suppressing treatme…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 26, 2026 13:17 UTC
-
New PET tracer aims to light up inflammation in joint and muscle diseases
Diagnosis Stopped earlyThis early-phase study tested a new radioactive imaging drug called 11C-MC1 to see if it can help detect inflammation in people with rheumatoid arthritis or idiopathic inflammatory myopathy, as well as in healthy volunteers. Participants received PET/CT scans after an injection o…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Diagnosis
Last updated Jun 26, 2026 18:25 UTC
-
Can osteopathy ease fibromyalgia pain?
Symptom relief Stopped earlyThis study tested whether osteopathic care (hands-on manipulation) can help reduce pain in people with fibromyalgia. 32 participants received osteopathic treatments over 8 months, with a follow-up 3 months later. The goal was to see if this approach could improve pain and quality…
Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Study seeks sweet spot for painkiller dose in Children's spine surgery
Symptom relief Stopped earlyThis study aimed to find the ideal dose of a spinal pain medicine (hydromorphone) for children undergoing back surgery for scoliosis. Researchers tested several doses in 31 patients to balance good pain control with fewer side effects. The trial was stopped early, so the results …
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Brain zaps for pain and fatigue: a quick fix?
Symptom relief Stopped earlyThis study looked at whether a brief, noninvasive brain stimulation technique called tDCS could immediately reduce pain and improve function in people with fibromyalgia or chronic fatigue syndrome. About 20 participants received one session, and researchers measured changes in pa…
Sponsor: Hospital Donostia • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Pain relief drug trial for mast cell syndrome stalls early
Symptom relief Stopped earlyThis Phase 2 trial tested whether FSD201 tablets could reduce chronic pain in adults with mast cell activation syndrome. The study planned to enroll many participants but was terminated early with only 2 people. No results are available to show if the drug works or is safe.
Phase 2 • Sponsor: Quantum Biopharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Personalized exercise coaching for fibromyalgia: a tiny trial that never got off the ground
Symptom relief Stopped earlyThis study aimed to see if a personalized physical activity program, with one face-to-face session followed by phone coaching, could improve quality of life for people with fibromyalgia compared to standard group exercise classes. The trial was terminated after enrolling only one…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Experimental pill for stomach paralysis shows promise in early trial
Symptom relief Stopped earlyThis study tested an oral drug called CIN-102 in 72 adults with gastroparesis (delayed stomach emptying) caused by diabetes or unknown reasons. Participants received one of three doses of CIN-102 or a placebo to see if it improved stomach emptying and reduced nausea. The trial wa…
Phase 2 • Sponsor: CinDome Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New pill aims to quiet debilitating cough in lung scarring disease
Symptom relief Stopped earlyThis study tested an experimental drug called BI 1839100 in adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF) who have a chronic cough. Participants took different doses of the drug or a placebo for 12 weeks. The goal was to see if the drug c…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New pill for stubborn hives shows promise, but trial halted early
Symptom relief Stopped earlyThis Phase 2 trial tested an experimental drug called EP262 in 113 people with chronic spontaneous urticaria (long-lasting hives with no clear cause). Participants took either EP262 or a placebo daily for 6 weeks, while continuing their usual antihistamines. The study aimed to se…
Phase 2 • Sponsor: Escient Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Virtual reality could help pinpoint the perfect exercise dose for dizziness relief
Symptom relief Stopped earlyThis study aimed to find the best amount of exercise needed to improve dizziness symptoms in people with balance disorders. Researchers used virtual reality (VR) to measure how much exercise helps and compared VR exercises to standard physical therapy. The study included people w…
Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could a tiny ear device ease arthritis pain in kids?
Symptom relief Stopped earlyThis study tested whether a small device that sends mild electrical pulses to the vagus nerve (through the ear) can reduce pain and inflammation in children with juvenile idiopathic arthritis. The trial planned to enroll children ages 5 to 18, but was terminated early after only …
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can a common numbing drug cut opioid use after teen spine surgery?
Symptom relief Stopped earlyThis study looked at whether giving teenagers a numbing medicine (lidocaine) through an IV during and after spine surgery could lower their need for strong painkillers (opioids) and help them recover faster. The trial planned to include 15 teens aged 12-18 with scoliosis, but it …
Phase 4 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New study tests safer pain control for teens after spine surgery
Symptom relief Stopped earlyThis study looked at two different combinations of anesthesia medicines given through an IV to teenagers having surgery for scoliosis. The goal was to see if one combination leads to less pain and less need for opioid painkillers after surgery. The study was small and ended early…
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New study tracks dupilumab for chronic hives in Real-World settings
Knowledge-focused Stopped earlyThis study watches 400 people with chronic spontaneous urticaria (long-lasting hives) who are prescribed dupilumab by their doctor. Researchers collect information from medical records and patient surveys to see how the drug works in real life, its safety, and how it affects qual…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New baby wearable aims to track health at home
Knowledge-focused Stopped earlyThis study tested a wearable device called JessieHug for newborns and infants. The goal was to see if parents find it easy to use, if babies tolerate wearing it, and if it collects accurate health data like oxygen levels. About 31 healthy infants participated, and parents used th…
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Scientists hunt for clues to tell infection apart from inflammation in Kids' joints
Knowledge-focused Stopped earlyThis study looked for new markers in blood and joint fluid to help doctors tell the difference between septic arthritis (a joint infection) and juvenile idiopathic arthritis (an inflammatory condition) in children. Researchers planned to analyze samples from 100 children under 15…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for genetic and environmental clues in rare lung disease
Knowledge-focused Stopped earlyThis study aimed to describe the features and natural history of idiopathic interstitial pneumopathy, a group of rare lung diseases, in both children and adults. Researchers planned to collect data from 1,600 participants, including medical history, imaging, and genetic tests, to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New lung camera could replace needle biopsies
Knowledge-focused Stopped earlyThis study aimed to see if a tiny camera on a thin tube (bronchoscopy) could help doctors diagnose diffuse lung diseases without needing a surgical lung biopsy. The camera takes live microscopic images of the air sacs. The study was stopped early, but it involved 38 adults with c…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gut microbiome study in kids with autoimmune diseases ends early
Knowledge-focused Stopped earlyThis study aimed to compare the gut bacteria of children newly diagnosed with juvenile idiopathic arthritis, type 1 diabetes, or inflammatory bowel disease with those of their healthy siblings. Researchers wanted to see if differences in gut microbes and diet could explain why so…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Sleep apnea machine tested for IPF lung health – but study stopped early
Knowledge-focused Stopped earlyThis study looked at whether using a CPAP machine at night could reduce abnormal acid reflux and lung inflammation in people with idiopathic pulmonary fibrosis (IPF) who also have sleep apnea. Only 7 people enrolled before the study was terminated early. The goal was to measure c…
Sponsor: University of Arizona • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Nerve activity study aims to unlock stomach disorder secrets
Knowledge-focused Stopped earlyThis observational study measured vagal nerve activity after eating in 43 people with gastroparesis (a stomach disorder) and healthy volunteers. The goal was to establish normal and abnormal nerve function patterns. The study used an FDA-approved device to track heart-based nerve…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:22 UTC